{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:29:51Z","timestamp":1776742191319,"version":"3.51.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T00:00:00Z","timestamp":1406505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1472-6874-14-88","type":"journal-article","created":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T05:01:26Z","timestamp":1406523686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Influences on visit retention in clinical trials: Insights from qualitative research during the VOICE trial in Johannesburg, South Africa"],"prefix":"10.1186","volume":"14","author":[{"given":"Busisiwe","family":"Magazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinead","family":"Delany-Moretlwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Mathebula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"van der Straten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,28]]},"reference":[{"issue":"5","key":"447_CR1","first-page":"1","volume":"6","author":"B M\u00e2sse","year":"2009","unstructured":"M\u00e2sse B, Boily M, Dimitrov D, Desai K: Efficacy dilution in randomized placebo-controlled vaginal microbicide trials. Emerg Themes Epidemiol. 2009, 6 (5): 1-8.","journal-title":"Emerg Themes Epidemiol"},{"issue":"18505","key":"447_CR2","first-page":"1","volume":"16","author":"C Woodsong","year":"2013","unstructured":"Woodsong C, MacQueen K, Amico KR, Friedland B, Gafos M, Mansoor L, Tolley E, McCormack S: Microbicide clinical trial adherence: insights for introduction. J Int AIDS Soc. 2013, 16 (18505): 1-9.","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"447_CR3","first-page":"1","volume":"5","author":"HA Weiss","year":"2008","unstructured":"Weiss HA, Wasserheit JN, Barnabas RV, Hayes RJ, Abu-Raddad LJ: Persisting with prevention: the importance of adherence for HIV prevention. Emerg Themes Epidemiol. 2008, 5 (8): 1-7.","journal-title":"Emerg Themes Epidemiol"},{"issue":"7","key":"447_CR4","doi-asserted-by":"publisher","first-page":"F13","DOI":"10.1097\/QAD.0b013e3283522272","volume":"26","author":"A van der Straten","year":"2012","unstructured":"van der Straten A, Van Damme L, Haberer JE, Bangsberg DR: Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS. 2012, 26 (7): F13-F19.","journal-title":"AIDS"},{"issue":"5, S1","key":"447_CR5","doi-asserted-by":"publisher","first-page":"S184","DOI":"10.1016\/S0197-2456(00)00076-3","volume":"21","author":"KE Kidd","year":"2000","unstructured":"Kidd KE, Altman DG: Adherence in social context. Control Clin Trials. 2000, 21 (5, S1): S184-S187.","journal-title":"Control Clin Trials"},{"issue":"1","key":"447_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.9734\/ISRR\/2013\/3531","volume":"1","author":"J Ambia","year":"2013","unstructured":"Ambia J, Agot K: Barriers and facilitators of adherence in user- dependent HIV prevention trials, a systematic review. International STD Research and Reviews. 2013, 1 (1): 12-29.","journal-title":"International STD Research and Reviews"},{"key":"447_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.cct.2011.03.008","volume":"32","author":"P Feldblum","year":"2011","unstructured":"Feldblum P, Helpern V, Lie C, Obunge O, Ogunsola F, Ampofo W, Opoku K: What predicts non-retention in microbicide trials. Contemp Clin Trials. 2011, 32: 512-516.","journal-title":"Contemp Clin Trials"},{"issue":"4","key":"447_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/01.qai.0000148532.12329.df","volume":"39","author":"G de Bruyn","year":"2005","unstructured":"de Bruyn G, Hudgens MG, Sullivan PS, Duerr AC: Participant retention in clinical trials of candidate HIV vaccines. J Acquir Immune Defic Syndr. 2005, 39 (4): 499-501.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"447_CR9","volume-title":"UNAIDS Report on the Global AIDS Epidemic","author":"United Nations","year":"2013","unstructured":"United Nations: UNAIDS Report on the Global AIDS Epidemic. 2013, Geneva: United Nations"},{"issue":"suppl 4","key":"447_CR10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/01.aids.0000341775.94123.75","volume":"22","author":"MF Chersich","year":"2008","unstructured":"Chersich MF, Rees VH: Vulnerability of women in Southern Africa to infection with HIV: biological determinants and priority health sector interventions. AIDS. 2008, 22 (suppl 4): S1-S14.","journal-title":"AIDS"},{"key":"447_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.bpobgyn.2012.01.006","volume":"26","author":"QA Karim","year":"2012","unstructured":"Karim QA, Humphries H, Stein Z: Empowering women in human immunodeficiency virus prevention. Best Pract Res Clin Obstet Gynaecol. 2012, 26: 487-493.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"11","key":"447_CR12","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.3201\/eid1011.040252","volume":"10","author":"AE Pettifor","year":"2004","unstructured":"Pettifor AE, Measham D, Rees H, Padian N: Sexual power and HIV risk, South Africa. Emerg Infect Dis. 2004, 10 (11): 1996-2004.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"447_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.cct.2009.05.002","volume":"30","author":"S Gappoo","year":"2009","unstructured":"Gappoo S, Montgomery ET, Gerdts C, Naidoo S, Chidanyika A, Nkala B, Ramjee G, MIRA Team: Novel strategies implemented to ensure high participant retention rates in a community based HIV prevention effectiveness trial in South Africa and Zimbabwe. Contemp Clin Trials. 2009, 30 (5): 411-418.","journal-title":"Contemp Clin Trials"},{"key":"447_CR14","volume-title":"Conference of Retroviral and Opportunistic Infections","author":"J Marrazzo","year":"2013","unstructured":"Marrazzo J, Ramjee G, Nair G, Palanee T, Mkhize B, Nakabiito C, Taljaard M, Piper J, Gomez K, Chirenje M: Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir\/emtricitabine, or vaginal tenofovir gel in the voice study (MTN003). Abstract#26LB. Conference of Retroviral and Opportunistic Infections. 2013, Atlanta, USA: Georgia World Congress Centre"},{"issue":"2","key":"447_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0089118","volume":"9","author":"A van der Straten","year":"2014","unstructured":"van der Straten A, Stadler J, Montgomery E, Hartmann M, Magazi B: Women\u2019s experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PLoS One. 2014, 9 (2): 1-12.","journal-title":"PLoS One"},{"issue":"1","key":"447_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1001369","volume":"10","author":"NC Ware","year":"2013","unstructured":"Ware NC, Wyatt MA, Geng EH, Kaaya SF, Agbaji OO, Muyindike WR, Chalamilla G, Agaba PA: Toward an understanding of disengagement from HIV treatment and care in Sub-Saharan Africa: a qualitative study. PLoS Med. 2013, 10 (1): 1-10.","journal-title":"PLoS Med"},{"issue":"6","key":"447_CR17","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1177\/0306312712457707","volume":"42","author":"C Montgomery","year":"2012","unstructured":"Montgomery C: Making Prevention Public: The co-production of gender and technology in HIV prevention research. Soc Stud Sci. 2012, 42 (6): 922-944.","journal-title":"Soc Stud Sci"},{"key":"447_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2147\/PPA.S30759","volume":"6","author":"C McPhail","year":"2012","unstructured":"McPhail C, Delany-Moretlwe S, Mayaud P: \u2018It\u2019s not about money, it\u2019s about my health\u2019: determinants of participation and adherence among women in an HIV-HSV 2 prevention trial in Johannesburg, South Africa. Patient Prefer Adherence. 2012, 6: 579-588.","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"447_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-4505-9-1","volume":"9","author":"S Delany-Moretlwe","year":"2011","unstructured":"Delany-Moretlwe S, Stadler J, Mayaud P, Rees H: Investing in the future: Lessons learned from communicating the results of HSV\/HIV intervention in South Africa. Health Res Policy Syst. 2011, 9 (1): 1-9.","journal-title":"Health Res Policy Syst"},{"key":"447_CR20","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s10461-011-9927-9","volume":"15","author":"S Kunutsor","year":"2011","unstructured":"Kunutsor S, Walley J, Katabira E, Muchuro S, Balidalwa H, Namagala E, Ikoona E: Improving clinic attendance and adherence to antiretroviral therapy through a treatment supporter intervention in Uganda: a randomized controlled trial. AIDS Behav. 2011, 15: 1795-1802.","journal-title":"AIDS Behav"},{"issue":"12","key":"447_CR21","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.socscimed.2011.04.021","volume":"72","author":"C Scott","year":"2011","unstructured":"Scott C, Walker J, White P, Lewith G: Forging convictions: The effects of active participation in a clinical trial. Soc Sci Med. 2011, 72 (12): 2041-2048.","journal-title":"Soc Sci Med"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-14-88.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6874-14-88\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-14-88","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6874-14-88.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:58:11Z","timestamp":1630558691000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/1472-6874-14-88"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,28]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["447"],"URL":"https:\/\/doi.org\/10.1186\/1472-6874-14-88","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,28]]},"assertion":[{"value":"21 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"88"}}